Potent carcinogenicity of cigarette smoke in mice exposed early in life

Carcinogenesis

Volumn 28, Issue 10, 2007, Pages 2236-2243

  Balansky, Roumen ^a,b   Ganchev, Gancho ^b   Iltcheva, Marietta ^b   Steele, Vernon E ^c   D'Agostini, Francesco ^a   De Flora, Silvio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b National Oncology Center Bulgaria   (Bulgaria)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; CIGARETTE SMOKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BODY WEIGHT; BRONCHUS DISEASE; CANCER INCIDENCE; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOGENICITY; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENDER BIAS; HISTOPATHOLOGY; HYPERPLASIA; LIVER CANCER; LUNG ADENOMA; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; LUNG CARCINOGENESIS; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; TUMOR VASCULARIZATION; URINARY TRACT CANCER;

ANIMALS; ANIMALS, NEWBORN; BENZO(A)PYRENE; BODY WEIGHT; CARCINOGENS; ENVIRONMENTAL EXPOSURE; FEMALE; MALE; MICE; NEOPLASMS; SMOKING; TOBACCO SMOKE POLLUTION; WEIGHT GAIN;

EID: 35148900774     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm122     Document Type: Article

References (71)

1. Hoffman,F.L. (1931) Cancer and smoking habits. In Adair,F.E. (ed.) Cancer: International Contribution to the Study of Cancer in Honor of James Ewing. Lippincott, Philadelphia, PA, pp. 50-67.
2. Wynder,E.L. et al. (1950) Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. J. Am. Med. Assoc., 143, 329-336.
3. Doll,R. et al. (1950) Smoking and carcinoma of the lung; preliminary report. Br. Med. J., 2, 739-748.
4. Doll,R. et al. (1981) The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J. Natl Cancer Inst., 66, 1191-1308.
5. US Department of Health and Human Services. (1989) Reducing the Health Consequences of Smoking, 25 years of Progress, Office on Smoking and Health, DHSS Publication, No. CDC-89-8411. Government Printing Office, Washington, DC, pp. 43-54.
6. International Agency for Research on Cancer. (1986) Tobacco Smoking. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemical to Humans, IARC, Lyon, 38, 127-139.
7. International Agency for Research on Cancer. (2004) Tobacco Smoke and Involuntary Smoking. IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans. IARC, Lyon, 83, 973-1003.
8. Hecht,S.S. (1999) Tobacco smoke carcinogens and lung cancer. J. Natl Cancer Inst., 91, 1194-1210.
9. Mertens,V.E. (1930) Zigarettenrauch, eine Ursache des Lungenkrebses. Z. Krebsforsch., 31, 82.
10. Lorenz,E. et al. (1943) The effects of breathing tobacco smoke on strain A mice. Cancer Res., 3, 123.
11. Coggins,C.R. (2002) A minireview of chronic animal inhalation studies with mainstream cigarette smoke. Inhal. Toxicol., 14, 991-1002.
12. Witschi,H. (2005) A/J mouse as a model for lung tumorigenesis caused by tobacco smoke: Strengths and weaknesses. Exp. Lung Res., 31, 3-18.
13. Witschi,H. (2005),The complexities of an apparently simple lung tumor model: The A/J mouse. Exp. Toxicol. Pathol., 57 (suppl. 1), 171-181.
14. Hecht,S.S. (2005) Carcinogenicity studies of inhaled cigarette smoke in laboratory animals: Old and new. Carcinogenesis, 26, 1488-1492.
15. Witschi,H. et al. (1997) The carcinogenicity of environmental tobacco smoke. Carcinogenesis, 18, 575-586.
16. D'Agostini,F. et al. (2001) Pilot studies evaluating the lung tumor yield in cigarette smoke-exposed mice. Int. J. Oncol., 18 607-615.
17. De Flora,S. et al. (2003) Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke. Cancer Res., 63, 793-800.
18. Curtin,G.M. et al. (2004) Lung tumorigenicity in A/J and rasH2 transgenic mice following mainstream tobacco smoke inhalation. Toxicol. Sci., 81, 26-34.
19. Stinn,W. et al. (2005) Mechanisms involved in A/J mouse lung tumorigenesis induced by inhalation of an environmental tobacco smoke surrogate. Inhal. Toxicol., 17, 263-276.
20. Witschi,H. et al. (1997) The carcinogenic potential of the gas phase of environmental tobacco smoke. Carcinogenesis, 18, 2035-2042.
21. Stinn,W. et al. (2006) Lung tumor response in Swiss SWR and A/J mice after exposure to cigarette mainstream smoke. In Proceedings of 97th Annual Meeting of the American Association for Cancer Research, AACR, Philadelphia, PA (abstract no. 2850).
22. Mauderly,J.L. et al. (2004) Chronic inhalation exposure to mainstream cigarette smoke increases lung and nasal tumor incidence in rats. Toxicol. Sci., 81, 280-292.
23. Hutt,J.A. et al. (2005). Life-span inhalation exposure to mainstream cigarette smoke induces lung cancer in B6C3F1 mice through genetic and epigenetic pathways. Carcinogenesis, 26, 1999-2009.
24. De Flora,S. et al. (2003) Modulation of cigarette smoke-related end-points in mutagenesis and carcinogenesis. Mutat. Res., 523-524, 237-252.
25. De Flora,S. et al. (2007) Molecular and cytogenetical alterations induced by environmental cigarette smoke in mice heterozygous for Fhit. Cancer Res., 67, 1001-1006.
26. Izzotti,A. et al. (2003) Birth-related genomic and transcriptional changes in mouse lung. Modulation by transplacental N-acetylcysteine. Mutat. Res., 544, 441-449.
27. Bonner,A.E. et al. (2004) Molecular profiling of mouse lung tumors: Association with tumor progression, lung development, and human lung adenocarcinomas. Oncogene, 23, 1166-1176.
28. Anderson,L.M. (2004) Introduction and overview. Perinatal carcinogenesis: Growing a node for epidemiology, risk management, and animal studies. Toxicol. Appl. Pharmacol., 199, 85-90.
29. Mei,N. et al. (2005) Age-dependent sensitivity of Big Blue transgenic mice to the mutagenicity of N-ethyl-N-nitrosourea (ENU) in liver. Mutat. Res., 572, 14-26.
30. Agrawal,A.K. et al. (2005) Neonatal phenobarbital imprints overexpression of cytochromes P450 with associated increase in tumorigenesis and reduced life span. FASEB J., 19, 470-472.
31. Wiencke,J.K. et al. (2002) Teen smoking, field cancerization, and a "critical period" hypothesis for lung cancer susceptibility. Environ. Health Perspect., 110, 555-558.
32. Winterhalder,R.C. et al. (2004) Chemoprevention of lung cancer - from biology to clinical reality. Ann. Oncol., 15, 185-196.
33. Pietra,G. et al. (1959) Response of newly born mice to a chemical carcinogen. Nature, 183, 1689.
34. Fu,P.P. et al. (2000) Metabolic activation capacity of neonatal mice in relation to the neonatal mouse tumorigenicity bioassay. Drug Metab. Rev., 32, 241-266.
35. Beebe,L.E. et al. (1993) Comparison of transplacental and neonatal initiation of mouse lung and liver tumors by N-nitrosodimethylamine (NDMA) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and promotability by a polychlorinated biphenyls mixture (Aroclor 1254). Carcinogenesis, 14, 1545-1548.
36. Buening,M.K. et al. (1978) Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides in newborn mice: Exceptional activity of (+)-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene. Proc. Natl Acad. Sci. USA, 75, 5358-5361
37. Fujii,K. (1991) Evaluation of the newborn mouse model for chemical tumorigenesis. Carcinogenesis, 12, 1409-1415.
38. Yun,T.K. (1991) Usefulness of medium-term bioassay determining formations of pulmonary adenoma in NIH(GP) mice for finding anticarcinogenic agents from natural products. J. Toxicol. Sci., 16 (suppl. 1), 53-62.
39. Yun,T.K. et al. (1995) Trial of a new medium-term model using benzo(a)-pyrene induced lung tumor in newborn mice. Anticancer Res, 15, 839-845.
40. Amin,S. et al. (1995) Tumorigenicity in newborn mice of fjord region and other sterically hindered diol epoxides of benzo[g]chrysene, dibenzo[a,l]-pyrene (dibenzo[def,p]chrysene), 4H-cyclopenta[def]chrysene and fluoranthene. Carcinogenesis, 16, 2813-2817.
41. Chang,R.L. et al. (2000) Tumorigenicity of four optically active bay-region 3,4-diol 1, 2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine on mouse skin and in newborn mice. Carcinogenesis, 21, 1997-2003.
42. Platt,K.L. et al. (2004) Tumor formation in the neonatal mouse bioassay indicates that the potent carcinogen dibenzo[def,p]chrysene (dibenzo[a,l]-pyrene) is activated in vivo via its aws-11,12-dihydrodiol. Chem. Biol. Interact., 148, 27-36.
43. Samarth,R.M. et al. (2006) Protective effects of Mentha piperita Linn on benzo[a]pyrene-induced lung carcinogenicity and mutagenicity in Swiss albino mice. Mutagenesis, 21, 61-66.
44. Witschi,H. et al. (2002) A mouse lung tumor model of tobacco smoke carcinogenesis. Toxicol. Sci., 68, 322-330.
45. Balansky,R. et al. (1987) Investigation of the mutagenic activity of tobacco smoke. Mutat. Res., 188, 13-19.
46. Balansky,R. et al. (1992) Protection by N-acetylcysteine of the histopathological and cytogenetical damage produced by exposure of rats to cigarette smoke. Cancer Lett., 64, 123-131.
47. Balansky,R. et al. (1999) Induction, persistence and modulation of cytogenetic alterations in cells of smoke-exposed mice. Carcinogenesis, 20, 1491-1497.
48. Bagnasco,M. et al. (1992) Metabolic alterations produced by cigarette smoke in rat lung and liver, and their modulation by oral N-acetylcysteine. Mutagenesis, 7, 295-301.
49. Balansky,R. et al. (1996) Induction by carcinogens and chemoprevention by N-acetylcysteine of adducts to mitochondrial DNA in rat organs. Cancer Res., 56, 1642-1647.
50. D'Agostini,F. et al. (2001) Modulation of apoptosis by cigarette smoke and cancer chemoproventive agents in the respiratory tract of rats. Carcinogenesis, 22, 375-380.
51. Izzotti,A. et al. (2003) Genomic and transcriptional alterations in mouse fetus liver after transplacental exposure to cigarette smoke. FASEB J., 17, 1127-1129.
52. Izzotti,A. et al. (2004) Gene expression in the lung of p53 mutant mice exposed to cigarette smoke. Cancer Res., 64, 8566-8572.
53. Izzotti,A. et al. (2005) Chemoprevention of genome, transcriptome, and proteome alterations induced by cigarette smoke in rat lung. Eur. J. Cancer, 41, 1864-1874.
54. Schuller,H.M. et al. (2000) Interaction of tobacco-specific toxicants with the neuronal alpha(7) nicotinic acetylcholine receptor and its associated mitogenic signal transduction pathway: Potential role in lung carcinogenesis and pediatric lung disorders. Eur J Pharmacol. 393, 265-277.
55. Cutz,E. et al. (1985) Neuroendocrine celts in the developing human lung: Morphologic and functional considerations. Pediatr. Pulmonol. 1 (suppl. 3), S21-S29.
56. Zang,E.A. et al. (1996) Differences in lung cancer risk between men and women: Examination of the evidence. J. Natl Cancer Inst., 88, 183-192.
57. Stabile,L.P. et al. (2003) Sex and gender differences in lung cancer. J. Gend. Specif. Med., 6, 37-48.
58. Kreuzer,M. et al. (2000) Gender differences in lung cancer risk by smoking: A multicentre case-control study in Germany and Italy. Br. J. Cancer, 82, 227-233.
59. Mollerup,S. et al. (2006) Sex differences in risk of lung cancer: expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts. Int. J. Cancer, 119, 741-744.
60. Gasperino,J. et al. (2004) Gender and lung cancer. Clin. Lung Cancer, 5, 353-359.
61. Stabile,L.P. et al. (2004) Estrogen receptor pathways in lung cancer. Curr. Oncol. Rep., 6, 259-267.
62. Nicolov,I.G. et al. (1979) Tumors and hyperplastic lesions in Syrian hamsters following transplacental and neonatal treatment with cigarette smoke condensate. J. Cancer Res. Clin. Oncol., 94, 249-256.
63. Phillips,D.H. (2002) Smoking-related DNA and protein adducts in human tissues. Carcinogenesis, 23, 1979-2004.
64. Izzotti,A. et al. (2001) Modulation of biomarkers by chemopreventive agents in smoke-exposed rats. Cancer Res., 61 2472-2479.
65. Balansky,R. et al. (2006) Influence of FHIT on benzo[a]pyrene-induced tumors and alopecia in mice: Chemoprevention by budesonide and N-acetylcysteine. Proc. Natl Acad. Sci. USA, 103 7823-7828.
66. Yee,M. et al. (2006) Type II epithelial cells are critical target for hyperoxia-mediated impairment of postnatal lung development. Am. J. Physiol. Lung Cell. Mol. Physiol., 291, L1101-L1111.
67. Foster,J.J. et al. (2006) Galectin-1 in secondary alveolar septae of neonatal mouse lung. Am. J. Physiol. Lung Cell. Mol. Physiol., 291, L1142-L1149.
68. Shupe,T. et al. (2004) Low hepatic glutathione S-transferase and increased hepatic DNA adduction contribute to increased tumorigenicity of aflatoxin B1 in newborn and partially hepatectomized mice. Toxicol. Lett., 148, 1-9.
69. Coccia,P. et al. (1988) Liver DNA alkylation after a single carcinogenic dose of dimethylnitrosamine to newborn and adult CFW Swiss mice. Chem. Biol. Interact., 68, 259-271.
70. Hanaoka,F. et al. (1983) Changes in DNA polymerases alpha, beta and gamma in mouse liver as a function of age. Mech. Ageing Dev., 23, 315-327.
71. De Flora,S. et al. (2006) Induction by 7,12-dimethylbenz(a)anthracene of molecular and biochemical alterations in transformed human mammary epithelial stem cells, and protection by N-acetylcysteine, Int. J. Oncol., 29, 521-529.